- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir ; volume:13 ; number:12 ; day:26 ; month:10 ; year:2024 ; pages:2545-2561 ; date:12.2024
Infectious diseases and therapy ; 13, Heft 12 (26.10.2024), 2545-2561, 12.2024
- Creator
-
Hendrick, Victoria
Pohorylo, Erast
Merchant, Lubna
Gerhart, Jackie
Arham, Iqra Naz
Draica, Florin
Quercia, Romina
Ayoub, Ayman
Mehta, Reema
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40121-024-01050-w
- URN
-
urn:nbn:de:101:1-2502072127361.185437466261
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hendrick, Victoria
- Pohorylo, Erast
- Merchant, Lubna
- Gerhart, Jackie
- Arham, Iqra Naz
- Draica, Florin
- Quercia, Romina
- Ayoub, Ayman
- Mehta, Reema
- SpringerLink (Online service)
Other Objects (12)
High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment
Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling
Predicting the risk of drug–drug interactions in psychiatric hospitals: a retrospective longitudinal pharmacovigilance study
Clinically relevant enantiomer specific R- and S-praziquantel pharmacokinetic drug-drug interactions with efavirenz and ritonavir
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
A Feasibility Study of Drug–Drug Interaction Signal Detection in Regular Pharmacovigilance
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
DPDDI: a deep predictor for drug-drug interactions
Evaluation of the drug-drug interactions management system for appropriate use of nirmatrelvir/ritonavir: a retrospective observational study
Adverse reactions of immune checkpoint inhibitors combined with Proton pump inhibitors: a pharmacovigilance analysis of drug-drug interactions
High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment
Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling
Predicting the risk of drug–drug interactions in psychiatric hospitals: a retrospective longitudinal pharmacovigilance study
Clinically relevant enantiomer specific R- and S-praziquantel pharmacokinetic drug-drug interactions with efavirenz and ritonavir
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
A Feasibility Study of Drug–Drug Interaction Signal Detection in Regular Pharmacovigilance
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
DPDDI: a deep predictor for drug-drug interactions
Evaluation of the drug-drug interactions management system for appropriate use of nirmatrelvir/ritonavir: a retrospective observational study
Adverse reactions of immune checkpoint inhibitors combined with Proton pump inhibitors: a pharmacovigilance analysis of drug-drug interactions
High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment
Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling
Predicting the risk of drug–drug interactions in psychiatric hospitals: a retrospective longitudinal pharmacovigilance study
Clinically relevant enantiomer specific R- and S-praziquantel pharmacokinetic drug-drug interactions with efavirenz and ritonavir
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
A Feasibility Study of Drug–Drug Interaction Signal Detection in Regular Pharmacovigilance
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
DPDDI: a deep predictor for drug-drug interactions
Evaluation of the drug-drug interactions management system for appropriate use of nirmatrelvir/ritonavir: a retrospective observational study